Healix Infusion Therapy, Inc. v. Helix Health, LLC

747 F. Supp. 2d 730, 2010 U.S. Dist. LEXIS 103619, 2010 WL 3909481
District Court, S.D. Texas·Decided September 30, 2010·No. Civil Action H-09-2072·Published·Cited by 5 cases

Opinion

FINDINGS OF FACT AND CONCLUSIONS OF LAW

NANCY F. ATLAS, District Judge.

Plaintiff Healix Infusion Therapy, Inc. (“HIT”) filed this breach of contract action against Defendants Helix Health, L.L.C. and Steven Murphy (collectively “Defendants”) alleging that Defendants breached a settlement agreement with HIT. The Court has subject matter jurisdiction pursuant to 28 U.S.C. §§ 1331, 1332, 1338 and 1367, and Defendants have consented to enforcement of the settlement agreement in the Southern District of Texas. 1

This case was tried to the Court on September 23 and 24, 2010. 2 Each party presented exhibits and live witnesses. Having considered the evidence introduced by the parties, all matters of record in this case, the arguments of counsel and applicable authorities, the Court makes the following findings of fact and conclusions of law. 3

*735 I. BACKGROUND

This litigation arises out of a prior case resolved by a settlement agreement between the parties. HIT provides “drug compounding, infusion therapy and practice management services to physicians.” 4 HIT filed suit in January, 2008 against Defendants Stephen Murphy, a medical doctor specializing in internal medicine and genetics, and his business entity Helix Health, L.L.C., for cybersquatting and trademark infringement (the “Underlying Litigation”). In that case, HIT’s cybersquatting claim was adjudicated on summary judgment in favor of Defendants, and HIT’s trademark infringement claim was dismissed without prejudice for lack of personal jurisdiction. On May 1, 2009, while the Underlying Litigation was on appeal to the Fifth Circuit, the parties entered into a settlement agreement (the “Settlement Agreement”). 5

The basic terms of the Settlement Agreement were: (1) HIT paid Defendants $7,500.00; (2) HIT withdrew its appeal of the Underlying Litigation; (3) HIT agreed not to bring suit against Defendants for prior acts of trademark infringement; and (4) Defendants agreed (a) to abandon their trademark application for “HELIX HEALTH” within three days; (b) to provide HIT with a list of domain names previously used to market “Helix Health”; (c) to transfer ownership of the aforementioned domain names to HIT within thirty days (by May 31, 2009); (d) to cease using “Helix Health” within thirty days; and (e) to change Defendants’ corporate name within six months (by November 1, 2009). Defendants were, however, permitted to use the following corporate identifiers: “Helix Health of Connecticut”, “Helix Health of Delaware”, and “Helix Health of New York”. 6

HIT commenced the suit at bar on July 2, 2009, alleging that Defendants have continued to use the identifier “Helix” in violation of the Settlement Agreement. HIT asserted claims for breach of the Settlement Agreement and for trademark infringement under the Lanham Act, 15 U.S.C. §§ 1114, 1125. HIT seeks specific performance of the Settlement Agreement, damages, a permanent injunction, and attorney’s fees. Defendants, alleging that HIT intercepted emails intended for Dr. Murphy following the domain transfer, assert counterclaims for breach of the Settlement Agreement, invasion of privacy, violations of the Federal Wiretap Act, 18 U.S.C. § 2520, and violations of the Federal Stored Communications Act, 18 U.S.C. § 2707.

On January 19, 2010, Defendants agreed to a preliminary injunction [Doc. # 43] enjoining them from using the prohibited marks in any manner outside the terms of the Settlement Agreement. In March 2010, HIT moved for summary judgment on its breach of contract and trademark infringement claims, as well as Defendants’ counterclaims. Defendants moved for partial summary judgment on HIT’s claims. On August 12, 2010, 737 F.Supp.2d 648, 2010 WL 3218881 (S.D.Tex. 2010), the Court denied HIT’s motion for summary judgment, while granting in part and denying in part Defendants’ motion [Doc. # 71].

On September 8, 2010, the parties stipulated [Doc. # 82] that HIT abandoned with prejudice its claim for trademark infringement and Defendants dismissed with prejudice their counterclaims for breach of *736 contract, invasion of privacy, and violations of the Federal Stored Communications Act, 18 U.S.C. § 2707. The only remaining claims became HIT’S cause of action for breach of contract and Defendants’ counterclaim for violations of the Federal Wiretap Act, cited as 18 U.S.C. § 2520. 7 The case proceeded to trial. 8

II. BREACH OF CONTRACT

A. Legal Principles

The construction and enforcement of the provisions of a settlement agreement are governed by Texas contract law. Eastern Energy, Inc. v. Unico Oil & Gas, Inc., 861 F.2d 1379, 1380 (5th Cir.1988); Lockette v. Greyhound Lines, Inc., 817 F.2d 1182, 1185 (5th Cir.1987) (holding that in diversity cases, state law controls validity and interpretation of settlement agreements). The elements of a breach of contract are (1) the existence of a valid contract, (2) performance or tendered performance by the plaintiff, (3) breach of the contract by the defendant, and (4) damages sustained by the plaintiff as a result of the breach. Valero Mktg. & Supply Co. v. Kalama Int’l, 51 S.W.3d 345, 351 (Tex. App.-Houston [1st Dist.] 2001, no pet.).

When a trademark infringement plaintiff has entered into a settlement agreement releasing its claim, what it bargained for was “the peaceable enjoyment of its trademark, without conduct that would infringe on that trademark.” Qaddura v. Indo-European Foods, Inc., 141 S.W.3d 882, 891-92 (Tex.App.-Dallas 2004, pet. denied).

Free access — add to your briefcase to read the full text and ask questions with AI

Healix Infusion Therapy, Inc. v. Helix Health, LLC, 747 F. Supp. 2d 730, 2010 U.S. Dist. LEXIS 103619, 2010 WL 3909481 (S.D. Tex. 2010).

747 F. Supp. 2d 730 (Healix Infusion Therapy, Inc. v. Helix Health, LLC) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related